in vitro News and Research

RSS

PrenaTest can be now performed for high risk pregnancies after ninth week

PrenaTest, Europe's first non-invasive molecular genetic blood test to determine fetal trisomies 13, 18 and 21 in the mother's blood can now be performed for high risk pregnancies after the ninth week (W 9 + D 0).

11 Jul 2013

Cancer immunotherapies promise to be a new tool in fight against cancer

Drugs that direct a cancer patient's immune system to eradicate her or his disease, known as cancer immunotherapies, promise to be a new tool in the fight against cancer. Since the Koch Institute's inception, exploring the close relationship between the immune system and cancer has been one of the Institute's priority research areas.

9 Jul 2013

New low-cost method of in-vitro fertilization may help infertile couples in developing countries

A new low-cost method of in-vitro fertilization developed at the University of Colorado Boulder that performed successfully in recent human clinical trials in Belgium may help thousands of infertile couples in developing countries.

9 Jul 2013

VBL Therapeutics publishes VB-201 pre-clinical data in journal of Atherosclerosis

VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, announced today the publication of pre-clinical data for VB-201 in the journal of Atherosclerosis.

8 Jul 2013

Study: ChemoFx chemoresponse assay can help identify platinum resistance in primary ovarian cancer

Precision Therapeutics, a leading life-science company dedicated to the improvement of patient outcomes in personalized medicine, today announced findings that support the ChemoFx chemoresponse assay as a tool to aid in the identification of platinum resistance in primary ovarian cancer, according to a presentation at the Annual Meeting of The Western Association of Gynecologic Oncologists June 26-29, in Seattle, Washington.

8 Jul 2013

Probiodrug to present studies on PQ912 for treatment of Alzheimer's disease at AAIC meeting

Probiodrug AG (Probiodrug) announced that it will be making two poster and two oral presentations at the upcoming Alzheimer's Association International Conference in Boston, MA July 13 - 18, 2013.

8 Jul 2013

BCSI, ORIGIO partner to advance pH monitoring solutions for IVF

Blood Cell Storage, Inc., a leading medical device provider based in Seattle, WA and ORIGIO a/s, a leader in delivering innovative Assisted Reproductive Technology solutions headquartered in Malov Denmark, announced a partnership today during the annual meeting of the European Society of Human Reproduction and Embryology.

8 Jul 2013

New research shows that exercise changes expression of innate DNA

Exercise, even in small doses, changes the expression of our innate DNA. New research from Lund University in Sweden has described for the first time what happens on an epigenetic level in fat cells when we undertake physical activity.

4 Jul 2013

Medical ethicists find no justification to support UK's legal ban on sex selection

As Europe's leading fertility specialists gather at a conference in London this weekend, a major new publication from leading medical ethicists finds no justification to support the UK's legal ban on sex selection before pregnancy for 'social' reasons.

3 Jul 2013

Study: IVF treatment linked with increased risk of mental retardation

In a study that included more than 2.5 million children born in Sweden, compared with spontaneous conception, any in vitro fertilization (IVF) treatment was not associated with autistic disorder but was associated with a small but statistically significantly increased risk of mental retardation, according to a study in the July 3 issue of JAMA. The authors note that the prevalence of these disorders was low, and the increase in absolute risk associated with IVF was small.

3 Jul 2013

Researchers find NRF2 signaling plays a role in growth of tumor cells by altering metabolic pathways

Cancer cells have alteration in metabolic pathways as a result of oncogenes that promote tumor growth. NRF2 (nuclear factor erythroid-derived 2-related factor 2) works as a "master gene" that turns on stress response by increasing numerous antioxidants and pollutant-detoxifying genes to protect the lungs from variety of air pollutants such as diesel exhaust and cigarette smoke.

3 Jul 2013

BHR to demonstrate EKF Quo-Test HbA1c analyser at Heart UK's conference

EKF, announces today that the Quo-Test, its glycated haemoglobin analyser for near-patient monitoring of diabetes will be on show at Heart UK.

From EKF Diagnostics 2 Jul 2013

Key to treating neurodegenerative prion diseases may lie in ribosome, shows research

New research results from Uppsala University, Sweden, show that the key to treating neurodegenerative prion diseases such as mad cow disease and Creutzfeldt-Jakob disease may lie in the ribosome, the protein synthesis machinery of the cell. The results were recently published in the Journal of Biological Chemistry.

2 Jul 2013

Mixed results for acupuncture in improving IVF rates

Acupuncture, when used as a complementary or adjuvant therapy for in vitro fertilization (IVF), may be beneficial depending on the baseline pregnancy rates of a fertility clinic, according to research from the University of Maryland School of Medicine. The analysis from the University of Maryland Center for Integrative Medicine is published in the June 27 online edition of the journal Human Reproduction Update.

2 Jul 2013

UCSF researchers find that vitamin C may help stem cells, in vitro fertilization

Vitamin C affects whether genes are switched on or off inside mouse stem cells, and may thereby play a previously unknown and fundamental role in helping to guide normal development in mice, humans and other animals, a scientific team led by UC San Francisco researchers has discovered.

2 Jul 2013

Synthetic biology technology could lead to new antibiotics, modified protein-generators

Synthetic biology researchers at Northwestern University, working with partners at Harvard Medical School, have for the first time synthesized ribosomes -- cell structures responsible for generating all proteins and enzymes in our bodies -- from scratch in a test tube.

30 Jun 2013

Ingestion of nanoparticles at typical environmental levels unlikely to cause overt toxicity

Ingestion of commonly encountered nanoparticles at typical environmental levels is unlikely to cause overt toxicity, according to US researchers. Nevertheless there is insufficient evidence to determine whether chronic exposures could lead to subtle alterations in intestinal immune function, protein profiles, or microbial balance.

27 Jun 2013

Janssen, Johnson & Johnson Innovation establish IBD research alliance with Mount Sinai

Janssen Biotech, Inc. and Johnson & Johnson Innovation announced today the establishment of a research alliance with The Icahn School of Medicine at Mount Sinai to advance the scientific understanding of inflammatory bowel disease and the discovery of next generation therapeutic solutions.

27 Jun 2013

Study questions the beneficial effects of polyphenols on combating cardiovascular disease

Eating fruit or having a glass of red wine is seen as offering health benefits. The benefits are often pinned on polyphenols, natural chemicals—found in foods—referred to as flavonoids and phenolic acids, but also fragments of food proteins called peptides.

25 Jun 2013

Thirdhand smoke causes significant genetic damage in human cells

A study led by researchers from Lawrence Berkeley National Laboratory has found for the first time that thirdhand smoke-the noxious residue that clings to virtually all surfaces long after the secondhand smoke from a cigarette has cleared out-causes significant genetic damage in human cells.

21 Jun 2013

in vitro News and Research

PrenaTest can be now performed for high risk pregnancies after ninth week

Cancer immunotherapies promise to be a new tool in fight against cancer

New low-cost method of in-vitro fertilization may help infertile couples in developing countries

VBL Therapeutics publishes VB-201 pre-clinical data in journal of Atherosclerosis

Study: ChemoFx chemoresponse assay can help identify platinum resistance in primary ovarian cancer

Probiodrug to present studies on PQ912 for treatment of Alzheimer's disease at AAIC meeting

BCSI, ORIGIO partner to advance pH monitoring solutions for IVF

New research shows that exercise changes expression of innate DNA

Medical ethicists find no justification to support UK's legal ban on sex selection

Study: IVF treatment linked with increased risk of mental retardation

Researchers find NRF2 signaling plays a role in growth of tumor cells by altering metabolic pathways

BHR to demonstrate EKF Quo-Test HbA1c analyser at Heart UK's conference

Key to treating neurodegenerative prion diseases may lie in ribosome, shows research

Mixed results for acupuncture in improving IVF rates

UCSF researchers find that vitamin C may help stem cells, in vitro fertilization

Synthetic biology technology could lead to new antibiotics, modified protein-generators

Ingestion of nanoparticles at typical environmental levels unlikely to cause overt toxicity

Janssen, Johnson & Johnson Innovation establish IBD research alliance with Mount Sinai

Study questions the beneficial effects of polyphenols on combating cardiovascular disease

Thirdhand smoke causes significant genetic damage in human cells

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News